<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="131284">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT02123277</url>
  </required_header>
  <id_info>
    <org_study_id>9259</org_study_id>
    <nct_id>NCT02123277</nct_id>
  </id_info>
  <brief_title>Long Term Evaluation of Tubal Expansion on Obstructive Dysfunctions of Eustachian Tube</brief_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Montpellier</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital, Montpellier</source>
  <oversight_info>
    <authority>France: Committee for the Protection of Personnes</authority>
    <authority>France: Agence Nationale de Sécurité du Médicament et des produits de santé</authority>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The study aim is to evaluate the tubal score on patients who suffer from obstructive
      dysfunction of eustachian tube before the intervention and 12 months after the eustachian
      tube dilatation.

      This patients are refractory to the reference medical treatment.
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date>May 2014</start_date>
  <completion_date type="Anticipated">May 2017</completion_date>
  <primary_completion_date type="Anticipated">April 2015</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <study_design>Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment</study_design>
  <primary_outcome>
    <measure>Change in Tubal score</measure>
    <time_frame>at 1st day, and 2 months</time_frame>
    <safety_issue>Yes</safety_issue>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">30</enrollment>
  <condition>Chronic Dysfunction Eustachian Tube</condition>
  <arm_group>
    <arm_group_label>concept proof</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Balloon catheter for the Eustachian tube</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Balloon catheter for the Eustachian tube</intervention_name>
    <arm_group_label>concept proof</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  patients between 20 and 80 years old

          -  tubal score lower than 5

          -  patients who already used reference medical treatment

        Exclusion Criteria:

          -  patients who already do a major surgery of middle ear

          -  tympanic perforation

          -  pregnant or breastfeeding woman.

          -  patients who can't be follow during 14 months
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Frederic VENAIL</last_name>
    <phone>04 67 33 68 00</phone>
    <email>f-venail@chu-montpellier.fr</email>
  </overall_contact>
  <verification_date>April 2014</verification_date>
  <lastchanged_date>April 23, 2014</lastchanged_date>
  <firstreceived_date>March 3, 2014</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
